Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 255.19 Billion KRW | 34.91% |
| 2022 | 189.16 Billion KRW | -7.67% |
| 2021 | 204.87 Billion KRW | 14.19% |
| 2020 | 179.41 Billion KRW | 6.04% |
| 2019 | 169.19 Billion KRW | 3.54% |
| 2018 | 163.42 Billion KRW | 35.65% |
| 2017 | 120.47 Billion KRW | -19.14% |
| 2016 | 148.98 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 66.56 Billion KRW | 28.6% |
| 2024 Q1 | 51.76 Billion KRW | -6.74% |
| 2023 FY | 255.19 Billion KRW | 34.91% |
| 2023 Q2 | 67 Billion KRW | -6.64% |
| 2023 Q3 | 61.09 Billion KRW | -8.83% |
| 2023 Q4 | 55.49 Billion KRW | -9.15% |
| 2023 Q1 | 71.77 Billion KRW | 52.16% |
| 2022 Q2 | 52.84 Billion KRW | 11.6% |
| 2022 FY | 189.16 Billion KRW | -7.67% |
| 2022 Q4 | 47.16 Billion KRW | 12.84% |
| 2022 Q3 | 41.8 Billion KRW | -20.89% |
| 2022 Q1 | 47.34 Billion KRW | -18.12% |
| 2021 Q4 | 57.82 Billion KRW | 38.05% |
| 2021 FY | 204.87 Billion KRW | 14.19% |
| 2021 Q3 | 41.89 Billion KRW | 0.0% |
| 2020 FY | 179.41 Billion KRW | 6.04% |
| 2019 FY | 169.19 Billion KRW | 3.54% |
| 2018 FY | 163.42 Billion KRW | 35.65% |
| 2017 FY | 120.47 Billion KRW | -19.14% |
| 2016 FY | 148.98 Billion KRW | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| HLB Co., Ltd. | -6.01 Billion KRW | 4344.37% |
| iNtRON Biotechnology, Inc. | 4.56 Billion KRW | -5495.244% |
| BINEX Co., Ltd. | 56.65 Billion KRW | -350.429% |
| Bioneer Corporation | 199.25 Billion KRW | -28.074% |
| Anterogen.Co.,Ltd. | 2.21 Billion KRW | -11429.198% |
| MEDIPOST Co., Ltd. | 40.18 Billion KRW | -535.056% |
| CrystalGenomics, Inc. | 1.45 Billion KRW | -17414.821% |
| Helixmith Co., Ltd | 2.12 Billion KRW | -11926.852% |
| Medy-Tox Inc. | 128.16 Billion KRW | -99.117% |
| Peptron, Inc. | 1.14 Billion KRW | -22273.888% |
| Amicogen, Inc. | 51.51 Billion KRW | -395.395% |
| Genexine, Inc. | 387.48 Million KRW | -65758.549% |
| HLB Therapeutics Co.,Ltd. | 6.69 Billion KRW | -3712.103% |
| LegoChem Biosciences, Inc. | 17.79 Billion KRW | -1333.88% |
| ALTEOGEN Inc. | 31.19 Billion KRW | -717.961% |
| PharmaResearch Co., Ltd. | 182.25 Billion KRW | -40.019% |
| SillaJen, Inc. | 1.45 Billion KRW | -17417.978% |
| JETEMA, Co., Ltd. | 26.58 Billion KRW | -860.019% |
| OliX Pharmaceuticals,Inc | 14.42 Billion KRW | -1669.423% |
| Genomictree Inc. | -1.03 Billion KRW | 24670.909% |
| MedPacto, Inc. | -1.83 Billion KRW | 14024.632% |
| D&D Pharmatech | 18.67 Billion KRW | -1266.34% |
| EASY BIO,Inc. | 50.88 Billion KRW | -401.497% |
| GI Innovation, Inc. | 1.98 Billion KRW | -12727.431% |